The aim of this study is to present the casuistic of mucoepidermoid carcinoma of salivary glands in patients diagnosed at "Dr. Eduardo Cáceres Graziani" National Institute for Neoplastic Diseases, Lima, Perú. From January 2002 to December 2012, 51 cases were diagnosed as mucoepidermoid carcinoma. The number of female patients was higher, with 28 cases (54.9%), and regarding age distribution, 33.3% of the patients were under 30 years old. Pain was one of the main symptoms, and 74.5% of the mucoepidermoid carcinomas were located in the parotid gland. It is concluded that epidemiology regarding age and gender of the 51 cases analyzed was in the same range as other studies, and that most cases were located in major salivary glands, in agreement with reports on other populations. Other characte ristics showed a homogeneous distribution.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Renal Cell-Like Adenocarcinoma of Nasal Cavity: A Rare Entity Deserving Elucidation.
Indian J Otolaryngol Head Neck Surg
February 2025
Department of ENT, Command Hospital- Eastern Command, Kolkata, India.
Unlabelled: Sino-nasal malignancies are extremely rare accounting < 1% of all malignancies and < 3% of aero-digestive tract tumors. Their surgical pathology is extremely challenging due to the enormous heterogeneity. Few of these sino-nasal tumors may possibly present histologically as clear cell neoplasm.
View Article and Find Full Text PDFParotid Keratocystoma: Fine Needle Aspiration Cytomorphology With Ancillary Testing Results.
Diagn Cytopathol
April 2025
Department of Pediatric Oncology, Institut Curie, Paris cedex, France.
Keratocystoma is a rare benign salivary gland tumor described in 1999. Only 14 cases have been reported in the histopathological literature, with three of them having had a preoperative fine needle aspiration (FNA) performed. All cytological diagnoses were not specific.
View Article and Find Full Text PDFMicroscopic findings in oral squamous cell carcinoma with cystic spaces and clear cells mimicking mucoepidermoid carcinoma: A detailed case report.
Oral Oncol
February 2025
Department of Pathology, School of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil. Electronic address:
A 62-year-old male was referred for management of oral squamous cell carcinoma (OSCC), previously diagnosed in another service. The patient complained of persistent oral discomfort for 10 months, reported being a social drinker, and denied smoking. Intraoral examination revealed a vegetating, hardened lesion, measuring 3.
View Article and Find Full Text PDFSclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature.
J Med Case Rep
February 2025
Department of Pathology, West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China.
Background: Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia (SMECE) is a rare thyroid tumor. More and more reports have proposed that sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia is significantly invasive, but its origin and pathogenesis are currently controversial.
Case Presentation: We presented a 42-year-old female of Han ethnicity.
The Role of Immunotherapy in Salivary Gland Cancer: A Systematic Review.
Ear Nose Throat J
February 2025
Department of Otolaryngology-Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Salivary gland cancer (SGC) comprises a very heterogeneous group of rare neoplasms, accounting for approximately 2% to 6% of head and neck malignancies. Surgery with or without adjuvant radiotherapy is the main treatment regimen. However, patients who are ineligible for surgery, including late-stage, recurrent, or metastatic disease, have very limited options.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!